secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2025-12-04T23:59:59+00:00
Accession:  0001193125-25-308144
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Medical closes $148.4M public offering of 6.9M shares at $23.00
----------------------------------------------------------------------

- Offered 6,900,000 common shares at $23.00 per share, including full exercise of underwriters' over-allotment option of 900,000 shares.
- Net proceeds of approximately $148.4 million after underwriting discounts and estimated offering expenses.
- Proceeds to support sales/marketing, commercialization, R&D, clinical studies, and working capital.
- Underwriters included BofA Securities, Piper Sandler, J.P. Morgan, and Goldman Sachs; offering closed December 4, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000119312525308144/0001193125-25-308144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000119312525308144/d92377d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-308144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer